Cipla began its remarkable corporate journey in 1935 when it was founded as the Chemical, Industrial and Pharmaceutical Laboratories in Mumbai, India, driven by a nationalistic vision to make the country self-reliant in essential healthcare and medicine production. Over subsequent decades, the enterprise evolved from a modest domestic chemical producer into a global pharmaceutical powerhouse renowned for pioneering affordable access to life-saving medications, particularly its historic breakthrough in supplying low-cost antiretroviral drugs to combat HIV/AIDS across developing nations. Today, the company stands as an international multinational titan, delivering high-quality generic treatments, advanced respiratory devices, and specialized therapies to patients in numerous countries worldwide.